cordarone 50 mg/ml raztopina za injiciranje ali infundiranje
sanofi-aventis d.o.o. - amiodaron - raztopina za injiciranje/infundiranje - amiodaron 47,3 mg / 1 ml - amjodaron
amiodaronijev klorid lek 150 mg/3 ml koncentrat za raztopino za injiciranje/infundiranje
lek d.d. - amiodaron - koncentrat za raztopino za injiciranje/infundiranje - amiodaron 141,9 mg / 3 ml - amjodaron
cordarone 200 mg tablete
sanofi-aventis d.o.o. - amiodaron - tableta - amiodaron 189,3 mg / 1 tableta - amjodaron
opiodur 50 mikrogramov/uro transdermalni obliži
pharmabide ltd - fentanil - transdermalni obliž - fentanil 5,5 mg / 1 obliž - fentanil
opiodur 75 mikrogramov/uro transdermalni obliži
pharmabide ltd - fentanil - transdermalni obliž - fentanil 8,25 mg / 1 obliž - fentanil
opiodur 100 mikrogramov/uro transdermalni obliži
pharmabide ltd - fentanil - transdermalni obliž - fentanil 11 mg / 1 obliž - fentanil
opiodur 25 mikrogramov/uro transdermalni obliži
pharmabide ltd - fentanil - transdermalni obliž - fentanil 2,75 mg / 1 obliž - fentanil
amiodaron 200 mg tablete
tableta - amjodaron
amiodaron 200 mg tablete
tableta - amjodaron
kineret
swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - imunosupresivi - revmatoidni artritis (ra)kineret je navedeno pri odraslih za zdravljenje znakov in simptomov ra v kombinaciji z metotreksatom, z nezadosten odziv na sam metotreksat. covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml. periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret je treba v kombinaciji z colchicine, če je primerno. Še vedno je diseasekineret je navedeno pri odraslih, mladostnikov, otrok in dojenčkov, starih od 8 mesecev in več s telesno maso 10 kg ali več, za zdravljenje še vedno je bolezen, vključno s sistemsko mladoletnike idiopatsko artritis (sjia) in odrasle-nastop še vedno je bolezen (aosd), z aktivnim sistemske značilnosti zmerno do visoko aktivnosti bolezni, ali pri bolnikih s nadaljevanje aktivnosti bolezni po zdravljenju z nesteroidna protivnetna zdravila (nesteroidnih protivnetnih zdravil) ali glucocorticoids. kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).